跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RIXIMYO rituximab (rch) 100mg/10mL concentrated injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
RIXIMYO rituximab (rch) 100mg/10mL concentrated injection vial
Approved
STANDARD
RIXIMYO rituximab (rch) 100mg/10mL concentrated injection vial
Sandoz Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
0c7acc58a1b53f03
Company
Sandoz Pty Ltd
Type
Standard
Approval Details
Approval Id
0c7acc58a1b53f03
Product Name
RIXIMYO rituximab (rch) 100mg/10mL concentrated injection vial
Artg Id
281782
Artg Name
RIXIMYO rituximab (rch) 100mg/10mL concentrated injection vial
Sponsor
Sandoz Pty Ltd
Company Detail Path
/organization/sandoz-pty-ltd
Artg Date
2017-11-30
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/1bbb76031a7971671cb28ca89291efaf.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/955d3b644914e992add861151313d178.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
0c7acc58a1b53f03
Type
Standard
Back to TGA Approvals